Table 2.

miR-146a, -132, -9 and -15a levels in AD human brain.

				Braak stage
miRNA	Region	AMC	AD	III	IV
	TC	1.00 ± 0.10	3.63 ± 1.03*	1.52 ± 0.21	5.75 ± 1.69**
miR-146a	FC	1.00 ± 0.19	5.27 ± 1.86	1.44 ± 0.31	8.55 ± 2.98**
	CB	1.00 ± 0.14	3.73 ± 1.63	0.16 ± 0.02	6.80 ± 2.54**
	TC	1.00 ± 0.23	2.76 ± 0.76	1.11 ± 0.10	4.42 ± 1.21**
miR-132	FC	1.00 ± 0.26	1.48 ± 0.43	0.67 ± 0.12	2.18 ± 0.71
	CB	1.00 ± 0.31	0.10 ± 0.01**	0.12 ± 0.01*	0.10 ± 0.01*
	TC	1.00 ± 0.10	1.67 ± 0.32	1.02 ± 0.13	2.32 ± 0.52**
miR-9	FC	1.00 ± 0.17	1.22 ± 0.24	0.58 ± 0.07	1.78 ± 0.32*
	CB	1.00 ± 0.11	1.51 ± 0.42	0.58 ± 0.12	2.32 ± 0.63*
	TC	1.00 ± 0.09	1.25 ± 0.15	1.17 ± 0.14	1.32 ± 0.28
miR-15a	FC	1.00 ± 0.10	1.05 ± 0.12	0.71 ± 0.08	1.34 ± 0.15
	CB	1.00 ± 0.14	1.13 ± 0.18	0.74 ± 0.14	1.46 ± 0.26

^*AD patients (n=10) and age-matched controls (AMC, n=9). TC (temporal cortex), FC (frontal cortex) and CB (cerebellum).

Statistical significance:

^*p<0.05

^**p<0.01